Clinical Trials Browser

Terminated × Urinary Bladder Neoplasms × Mitomycin × Clear all

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01438112 2021-04-14

BOND

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT03335059 2020-04-15

RITE-USA

Phase 3 Terminated

5 enrolled

Genitourinary

Urinary Bladder Neoplasms, Disease

NCT01200992 2017-08-24

EMBARC-RF

Phase 3 Terminated

84 enrolled 7 charts

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Mycobacterium Infections, Neoplasm Recurrence, Local, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT00974818 2015-11-20

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Phase 3 Terminated

50 enrolled 7 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00042887 2012-09-24

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Phase 3 Terminated

58 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

ATLAS

BOND

RITE-USA

EMBARC-RF

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer